Objective: Sleep disorders are one of the most common problems in patients with malignancy and they severely decrease the quality of life. We ougt to investigate the frequency of sleep disturbances, its quantity, quality and possible correlation with related factors such as depression and anxiety.
Methods:150 patients participate and Pittsburgh Sleep Quality Index was used to evaluate the sleep quality. It is a self-administered questionnaire and standardized measure of sleep quality. Total score of ≥5 showes that quality of sleep is remarkably bad. Also a self-report measure of depression, the Beck Depression Inventory(BDI); and a self-report measure of anxiety, Beck Anxiety Inventory (BAI) were used.
Results: Of the 150 patients 74.0% has bad sleep quality (score >5 ). Mean PSQI total score was 7.34 (min 0-max 20). No difference was found between PSQI mean scores in terms of gender, radiotherapy (RT), chemotherapy (CHT), having chronic disease or having metastatic disease. NSAIDs and opioids were significantly correleted with PSQI (P<0.001). PSQI total scores are strongly associated with BDI score (r=.424 P<0.001) and BAI score (r=.417, P<0.001).
Conclusion: We found a high prevalence rate of bad sleep quality at 74%. Effective sleep treatment and psychological support should be provided in oncology clinics.
Sonuç: Sonuç olarak % 74 oranında yüksek bir kötü uyku kalitesi prevalans oranı bulduk. Bu da onkoloji kliniklerinde etkili uyku tedavisi ve psikolojik destek sağlanması gerektiğini ortaya koymaktadır.
Objective: Sleep disorders are one of the most common problems in patients with malignancy and they severely decrease the quality of life. We ougt to investigate the frequency of sleep disturbances, its quantity, quality and possible correlation with related factors such as depression and anxiety.
Methods:150 patients participate and Pittsburgh Sleep Quality Index was used to evaluate the sleep quality. It is a self-administered questionnaire and standardized measure of sleep quality. Total score of ≥5 showes that quality of sleep is remarkably bad. Also a self-report measure of depression, the Beck Depression Inventory(BDI); and a self-report measure of anxiety, Beck Anxiety Inventory (BAI) were used.
Results: Of the 150 patients 74.0% has bad sleep quality (score >5 ). Mean PSQI total score was 7.34 (min 0-max 20). No difference was found between PSQI mean scores in terms of gender, radiotherapy (RT), chemotherapy (CHT), having chronic disease or having metastatic disease. NSAIDs and opioids were significantly correleted with PSQI (P<0.001). PSQI total scores are strongly associated with BDI score (r=.424 P<0.001) and BAI score (r=.417, P<0.001).
Conclusion: We found a high prevalence rate of bad sleep quality at 74%. Effective sleep treatment and psychological support should be provided in oncology clinics.
Primary Language | English |
---|---|
Subjects | Clinical Sciences |
Journal Section | Orginal Article |
Authors | |
Publication Date | August 23, 2020 |
Published in Issue | Year 2020 Volume: 8 Issue: 2 |